AQUILA STUDY IN GERMANY - REAL WORLD ADHERENCE AND PERSISTENCE OF SECUKINUMAB TREATMENT IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS - AN INTERIM ANALYSIS

被引：8
|
作者：
Kiltz, Uta [1 ,2 ]
Peterlik, Daniel [3 ]
Winkelmann, Veronika [3 ]
Tony, Hans-Peter [4 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Ruhr Univ, Bochum, Germany
[3] Novartis Pharma GmbH, Clin Res Immunol Hepatol & Dermatol, Nurnberg, Germany
[4] Univ Klin, Med Klin 2, Rheumatol Immunol, Wurzburg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY; DOUBLE-BLIND;
D O I：
10.1136/annrheumdis-2019-eular.435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0705
引用
收藏
页码：1814 / 1815
页数：2
相关论文
共 50 条
  • [21] Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population
    Berman, Julia
    Furer, Victoria
    Berman, Mark
    Isakov, Ofer
    Zisman, Devy
    Haddad, Amir
    Elkayam, Ori
    BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 463 - 470
  • [22] Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study
    Joven, Beatriz
    Fito Manteca, Concepcion
    Rubio, Esteban
    Raya, Enrique
    Perez, Alba
    Hernandez, Raquel
    Manrique, Sara
    Nunez, Mercedes
    Diaz-Cerezo, Silvia
    Moyano, Sebastian
    Lacetera, Alessandra
    Garcia-Vicuna, Rosario
    ADVANCES IN THERAPY, 2023, 40 (12) : 5415 - 5431
  • [23] Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Weinstein, Cindy L. J.
    Meehan, Alan G.
    Lin, Jianxin
    Briscoe, Steven D.
    Govoni, Marinella
    CLINICAL RHEUMATOLOGY, 2023, 42 (12) : 3397 - 3405
  • [24] LONG-TERM GOLIMUMAB PERSISTENCE: 5-YEAR TREATMENT RETENTION DATA POOLED FROM FIVE PHASE III CLINICAL TRIALS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Weinstein, C.
    Govoni, M.
    Lin, J.
    Meehan, A.
    Qureshi, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 777 - 778
  • [25] Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors
    Mease, Philip J.
    Ferrante, Shannon A.
    Shiff, Natalie J.
    Fitzgerald, Timothy P.
    Chakravarty, Soumya D.
    Walsh, Jessica A.
    ADVANCES IN THERAPY, 2025, 42 (02) : 734 - 751
  • [26] Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors
    Walsh, Jessica A.
    Lin, Iris
    Zhao, Ruizhi
    Shiff, Natalie J.
    Morrison, Laura
    Emond, Bruno
    Yu, Louise H.
    Schwartzbein, Samuel
    Lefebvre, Patrick
    Pilon, Dominic
    Chakravarty, Soumya D.
    Mease, Philip
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (03) : 487 - 499
  • [27] Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
    Deodhar, A.
    Mease, P. J.
    McInnes, I. B.
    Baraliakos, X.
    Reich, K.
    Blauvelt, A.
    Leonardi, C.
    Porter, B.
    Gupta, A. Das
    Widmer, A.
    Pricop, L.
    Fox, T.
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [28] Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study
    Ak, Tumay
    Mustafayeva, Leyla
    Ayla, Ali Yagiz
    Celik, Yeliz
    Can, Gunay
    Ugurlu, Serdal
    ARCHIVES OF RHEUMATOLOGY, 2024, 39 (01) : 71 - 80
  • [29] Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: a Danish population-based cohort study
    Hansen, Rebekka L.
    Jorgensen, Tanja S.
    Egeberg, Alexander
    Roseno, Nana A. L.
    Skougaard, Marie
    Stisen, Zara R.
    Dreyer, Lene
    Kristensen, Lars Erik
    RHEUMATOLOGY, 2024, 63 (06) : 1593 - 1598
  • [30] Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan
    Okazaki, Masateru
    Kobayashi, Hisanori
    Shimizu, Hirohito
    Ishii, Yutaka
    Yajima, Tsutomu
    Kanbori, Masayoshi
    RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 135 - 148
12345